Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRAsia-Pacific Radiotherapy Market, By Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) - Industry Trends and Forecast to 2030.
Asia-Pacific Radiotherapy Market Analysis and Size
Asia-Pacific incidence of cancer was on the rise, and radiotherapy is a crucial treatment modality for many cancer types. As the population continues to age and lifestyles change, the number of cancer cases is expected to increase, driving demand for radiotherapy. Increased awareness about cancer and its treatment options, along with improved screening and early detection methods, led to more individuals seeking cancer treatments, including radiotherapy. In many countries, healthcare spending has been increasing, providing more funding for advanced treatments such as radiotherapy. Governments and private healthcare providers have been investing in upgrading their facilities and equipment.
Data Bridge Market Research analyzes that the Asia-Pacific radiotherapy market is expected to reach the value of USD 3,321.79 million by 2030, from USD 1,595.61 million in 2022, growing at a CAGR of 10.0% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, and Pricing in USD |
|
Segments Covered |
Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) |
|
Countries Covered |
China, Japan, Australia, India, South Korea, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines, and the Rest of Asia-Pacific. |
|
Market Players Covered |
Siemens Healthcare GmbH, Elekta, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Zeiss International, IBA Worldwide, CANON MEDICAL SYSTEMS CORPORATION, Accuray Incorporated, Mevion medical System, Brainlab AG, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”), and Nordion Inc. (A Subsidiary of Sotera Health) among others. |
Market Definition
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation that will be delivered to the patient's tumor and the surrounding normal tissue.
Asia-Pacific Radiotherapy Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Cancer Disease
The Asia-Pacific incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Cancer disease has a major impact Asia-Pacificly. Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel Technology in Radiotherapy for Cancer Treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
Opportunity
- Increasing Healthcare Expenditure for Cancer Treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure helps the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
Hence, the increasing healthcare expenditure for cancer treatment is expected to create an opportunity for market growth.
Restraint / Challenge
- Lack of Skilled and Certified Professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
The requirement for trained staff is a big issue for the radiotherapy market, due to which the lack of skilled and certified professionals, end users are not able to install advanced products of radiotherapy procedures, the reason, lack of skilled and certified professionals are expected to restrain market growth.
Asia-Pacific Radiotherapy Market Scope
The Asia-Pacific radiotherapy market is categorized into five notable segments which are on the basis of product and services, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Services
- Product
- Software
On the basis of product and services, the market is segmented into services, product, and software.
Type
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiotherapy/ Radiopharmaceuticals
- Others
On the basis of type, the market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/ radiopharmaceuticals, and others.
Application
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Lymphoma
- Liver Cancer
- Thyroid Cancer
- Brain Cancer
- Cervical Cancer
- Spine Cancer
- Others
On the basis of application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others.
End User
- Hospitals
- Radiation Therapy Centers
- Specialty Clinics
- Others
On the basis of end user, the market is segmented into hospitals, radiation therapy centers, specialty clinics, and others.
Distribution Channel
- Direct Tenders
- Third Party Distributors
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party distributors, and others.
Asia-Pacific Radiotherapy Market Regional Analysis/Insights
Asia-Pacific radiotherapy market is analyzed and market size insights and trends are provided by country, product and services, type, application, end user, and distribution channel as referenced above.
The countries covered in this market report are China, Japan, Australia, India, South Korea, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines, and Rest of Asia-Pacific.
China is expected to dominate the market with the largest market share due to advancements of healthcare system and rising prevalence of various types of cancer along with the largest patient pool.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Radiotherapy Market Share Analysis
Asia-Pacific radiotherapy market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major market players operating in the Asia-Pacific radiotherapy market are Siemens Healthcare GmbH, Elekta, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Zeiss International, IBA Worldwide, CANON MEDICAL SYSTEMS CORPORATION, Accuray Incorporated, Mevion medical Systems, Brainlab AG, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY), and NordionInc. (A Subsidiary of Sotera Health) and among others.
SKU-
